Citigroup Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $71
Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $75 to $71.
Filings · News reference
Trian Fund Management, L.P. Raises Share Stake In GE Healthcare Technologies INC. To 3.1M Shares; Cuts Share Stake In Invesco By 45.3% To 1.6M Shares; Change In Holdings Are As Of June 30, 2026, And Compared With The Previous Quarter Ended As Of March 31, 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.
Needham Reiterates Buy on GE HealthCare Techs, Maintains $93 Price Target
Needham analyst David Saxon reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains $93 price target.
'GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business' - WSJ Exclusive
https://www.wsj.com/health/healthcare/ge-healthcare-to-buy-sofie-for-nearly-1-billion-to-grow-medical-imaging-business-cfca0318
Morgan Stanley Maintains Equal-Weight on Invesco, Raises Price Target to $31
Chips, Asset Managers and Consumer Names Slide After Warsh's Press Conference: The 10 Biggest Losers
ON Semiconductor, Carlyle and Coeur Mining led decliners in the hour after the Fed chair spoke. Economists split on whether October or December brings another hike.